124 related articles for article (PubMed ID: 8501773)
1. Absent ras gene mutations in human adrenal cortical neoplasms and pheochromocytomas.
Moul JW; Bishoff JT; Theune SM; Chang EH
J Urol; 1993 Jun; 149(6):1389-94. PubMed ID: 8501773
[TBL] [Abstract][Full Text] [Related]
2. Point mutations of ras genes in human adrenal cortical tumors: absence in adrenocortical hyperplasia.
Yashiro T; Hara H; Fulton NC; Obara T; Kaplan EL
World J Surg; 1994; 18(4):455-60; discussion 460-1. PubMed ID: 7725728
[TBL] [Abstract][Full Text] [Related]
3. Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers.
Moley JF; Brother MB; Wells SA; Spengler BA; Biedler JL; Brodeur GM
Cancer Res; 1991 Mar; 51(6):1596-9. PubMed ID: 1998949
[TBL] [Abstract][Full Text] [Related]
4. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
5. Infrequent RAS oncogene mutations in human prostate cancer.
Moul JW; Friedrichs PA; Lance RS; Theune SM; Chang EH
Prostate; 1992; 20(4):327-38. PubMed ID: 1608859
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the p53 gene in human functional adrenal neoplasms.
Lin SR; Lee YJ; Tsai JH
J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
[TBL] [Abstract][Full Text] [Related]
7. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
[TBL] [Abstract][Full Text] [Related]
8. Detection of RAS mutations in archival testicular germ cell tumors by polymerase chain reaction and oligonucleotide hybridization.
Moul JW; Theune SM; Chang EH
Genes Chromosomes Cancer; 1992 Sep; 5(2):109-18. PubMed ID: 1381946
[TBL] [Abstract][Full Text] [Related]
9. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
10. p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 "hot spot" found in Taiwan.
Reincke M; Wachenfeld C; Mora P; Thumser A; Jaursch-Hancke C; Abdelhamid S; Chrousos GP; Allolio B
J Clin Endocrinol Metab; 1996 Oct; 81(10):3636-8. PubMed ID: 8855814
[TBL] [Abstract][Full Text] [Related]
11. p53 mutations in sporadic adrenocortical tumors.
Ohgaki H; Kleihues P; Heitz PU
Int J Cancer; 1993 May; 54(3):408-10. PubMed ID: 8509216
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of the c-myc gene in adrenocortical tumors and pheochromocytomas.
Liu J; Voutilainen R; Kahri AI; Heikkilä P
J Endocrinol; 1997 Feb; 152(2):175-81. PubMed ID: 9071974
[TBL] [Abstract][Full Text] [Related]
13. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis.
Namba H; Rubin SA; Fagin JA
Mol Endocrinol; 1990 Oct; 4(10):1474-9. PubMed ID: 2283998
[TBL] [Abstract][Full Text] [Related]
14. ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism.
Yoshimoto K; Iwahana H; Fukuda A; Sano T; Katsuragi K; Kinoshita M; Saito S; Itakura M
Jpn J Cancer Res; 1992 Oct; 83(10):1057-62. PubMed ID: 1452458
[TBL] [Abstract][Full Text] [Related]
15. PCR-SSCP analysis of human adrenocortical adenomas: absence of K-ras gene mutations.
Ocker M; Sachse R; Rico A; Hensen J
Exp Clin Endocrinol Diabetes; 2000; 108(8):513-4. PubMed ID: 11149627
[TBL] [Abstract][Full Text] [Related]
16. Mutational status of codons 12 and 13 of the N- and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas.
Pergolizzi RG; Kreis W; Rottach C; Susin M; Broome JD
Cancer Invest; 1993; 11(1):25-32. PubMed ID: 7678540
[TBL] [Abstract][Full Text] [Related]
17. Mutations of K-ras oncogene in human adrenal tumours in Taiwan.
Lin SR; Tsai JH; Yang YC; Lee SC
Br J Cancer; 1998 Apr; 77(7):1060-5. PubMed ID: 9569040
[TBL] [Abstract][Full Text] [Related]
18. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
19. Ras mutations in United Kingdom examples of oral malignancies are infrequent.
Chang SE; Bhatia P; Johnson NW; Morgan PR; McCormick F; Young B; Hiorns L
Int J Cancer; 1991 May; 48(3):409-12. PubMed ID: 2040536
[TBL] [Abstract][Full Text] [Related]
20. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]